hdm201
Showing 1 - 7 of 7
AML, Adult Trial in Berne (HDM201, Midostaurin)
Terminated
- AML, Adult
- HDM201
- Midostaurin
-
Berne, SwitzerlandDepartement of Medical Oncology, University Hospital Berne
Oct 3, 2022
Acute Myeloid Leukemia (AML), High-risk Myelodysplastic Syndrome (MDS) Trial in Worldwide (HDM201, MBG453, Venetoclax)
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- High-risk Myelodysplastic Syndrome (MDS)
- HDM201
- +2 more
-
Durham, North Carolina
- +8 more
Dec 13, 2022
Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in France (Pazopanib, HDM201)
Recruiting
- Advanced Soft-tissue Sarcoma
- Metastatic Soft-tissue Sarcoma
- Pazopanib
- HDM201
-
Bordeaux, France
- +4 more
May 5, 2022
Advanced Solid and Hematological TP53wt Tumors Trial in Worldwide (HDM201, ancillary treatment)
Completed
- Advanced Solid and Hematological TP53wt Tumors
- HDM201
- ancillary treatment
-
Boston, Massachusetts
- +14 more
May 20, 2021
Leukemia, Myeloid, Acute Trial (HDM201, cytarabine, anthracycline)
Withdrawn
- Leukemia, Myeloid, Acute
- HDM201
- +6 more
- (no location specified)
Jan 6, 2020
Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Trial in
Completed
- Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma
- PDR001
- +5 more
-
Santa Monica, California
- +24 more
Mar 11, 2022